ubmslateOT-logo-ubm

OT mobile menu

Search form

Topics:

Home

African American Patients Have Increased Mutation Rate in Genes Linked to Tobacco-Related Tumors

Increases in the TP53 mutation in African American men with tobacco-related cancers may be responsible for a poorer prognosis overall.

Image © Moon Light Photostudio/Shutterstock

Recent Content

The phase III ALCYONE study showed that daratumumab in combination with bortezomib, melphalan, and prednisone is a viable front-line option for myeloma patients who are not candidates for ASCT.

A recent study suggests that next-generation sequencing of circulating tumor DNA is feasible in carcinoma of unknown primary, which could facilitate targeted therapy for this hard-to-treat disease.

Circulating tumor cells isolated from early stages of lung cancer may be predictive of poor prognosis and could potentially be predictive biomarkers of disease recurrence.

Researchers have discovered a three-drug combo that may combat acute lymphoblastic leukemia by shutting down the production of nucleotides that activate a DNA replication stress response.

Using a CRISPR gene editing technique, researchers have identified dozens of new genes that create T-cell resistant cancer.

Researchers at St. Jude Children’s Research Hospital have discovered a vulnerability that may easily translate into new targeted drug therapies that block heme biosynthesis, killing leukemic cells.

A 39-year-old man presents with a mass in the right upper arm. What is your diagnosis?

By clicking Accept, you agree to become a member of the UBM Medica Community.